chartexchange

EOLS
Evolus, Inc. Common Stock
stockNASDAQ

At CloseNov 19, 2026 4:00:00 PM EST
6.99USD-1.132%(-0.08)870,976
After-hoursNov 19, 2026 4:00:30 PM EST
7.00USD+0.143%(+0.01)
Loading…
Loading…
462.66M
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
David Moatazedi
HQ
Newport Beach, CA, USA
Previous Close
$7.07
Beta
1.34
52-Week High
$9.31 2026-09-04
52-Week Low
$3.86 2026-03-30
SMA 50
$7.47
SMA 200
$6.41
Avg. Vol 10D
1.40M
Avg. Vol 30D
974,396
Avg. Vol 90D
924,972
Relative Vol
0.89
47.66M
0.4300%
5,500,000
305,717
EOLS Profile

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.

EOLS Performance
PeriodPriceDateChangeBeta
1W6.962026-11-13+0.43%5.025
1M7.372026-10-20-5.16%1.967
3M8.352026-08-20-16.29%1.753
6M6.592026-05-20+6.07%1.009
1Y6.622025-11-20+5.59%1.337
2Y12.632024-11-20-44.66%—
5Y6.382021-11-19+9.56%1.087
EOLS Stock Summary

Evolus, Inc. Common Stock (NASDAQ:EOLS) stock price today is $6.99, and today's volume is 870,976. EOLS is down 1.132% today. The 30 day average volume is 974,396. EOLS market cap is $462.66M with 66.19M shares outstanding.